Table 1.
Characteristic | Number (n= 355) | % |
---|---|---|
Microalbuminuria (mg/dL) | ||
Negative | 99 | 27.9 |
20 | 138 | 38.9 |
50 | 109 | 30.7 |
100 | 9 | 2.5 |
Proteinuria (mg/dL) | ||
Negative | 226 | 63.7 |
1+ (30) | 117 | 32.9 |
2+ (100) | 10 | 2.8 |
3+ (300) | 2 | 0.6 |
4+ (1000) | 0 | 0 |
eGFR by adjusted CG equation (ml/min/1.73m2) | ||
≥ 90 | 129 | 36.3 |
60–89 | 137 | 38.6 |
30–59 | 87 | 24.5 |
15–29 | 2 | 0.6 |
< 15 | 0 | 0 |
Rates of Renal Dysfunction by CG Equation | ||
Stage 0 (increased risk only) | 51 | 14.4 |
Stage 1 (eGFR ≥ 90 with proteinuria) | 78 | 22.0 |
Stage 2 (eGFR 60–89) | 137 | 38.6 |
Stage 3 (eGFR 30–59) | 87 | 24.5 |
Stage 4 (eGFR 15–29) | 2 | 0.6 |
Stage 5 (eGFR <15 ) | 0 | 0 |
Rates of Renal Dysfunction by MDRD Equation | ||
Stage 0 | 69 | 19.4 |
Stage 1 | 110 | 31.0 |
Stage 2 | 115 | 32.4 |
Stage 3 | 61 | 17.2 |
Stage 4 | 0 | 0 |
Stage 5 | 0 | 0 |